|
2023
|
Invention
|
Methods of treating cancer. Provided herein are methods for predicting efficacy of cancer therape... |
|
|
Invention
|
Anti-ilt4 compositions and methods. Provided herein are antibodies or antigen-binding fragments t... |
|
2022
|
P/S
|
Pharmaceuticals Used for Stimulating White Blood Cell Production
Injection Device for Pharmace... |
|
|
Invention
|
Ppary agonist for treatment of progressive supranuclear palsy.
Methods of treatment of progressi... |
|
2021
|
P/S
|
Pharmaceutical preparations for the treatment of oncological diseases and disorders. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of oncological
diseases and disorders. |
|
|
Invention
|
Fixed dose combinations of chs-131 and a dpp-4 inhibitor. Provided herein are fixed dose combinat... |
|
|
Invention
|
Fixed dose combinations of chs-131 and a ppar agonist. Provided herein are fixed dose combination... |
|
|
Invention
|
Fixed dose combinations of chs-131 and a sglt-2 inhibitor. Provided herein are fixed dose combina... |
|
|
Invention
|
Fixed dose combinations of chs-131 and a thyroid receptor beta agonist. γγ-mediated diseases or d... |
|
|
Invention
|
Fixed dose combinations of chs-131 and a fxr agonist. Provided herein are fixed dose combination ... |
|
|
Invention
|
Systems and methods for producing sterile injection devices. The present disclosure provides nove... |
|
|
P/S
|
pharmaceutical preparations for the treatment of oncological diseases and disorders |
|
|
P/S
|
Injection device for pharmaceutical preparations. |
|
|
P/S
|
Injection device for pharmaceutical preparations. |
|
2020
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune
diseases. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases. |
|
|
Invention
|
Compositions and methods to treat non-alcoholic fatty liver diseases (nafld).
Provided herein ar... |
|
|
Invention
|
Compositions and methods to treat non-alcoholic fatty liver diseases (nafld). Provided herein are... |
|
|
Invention
|
Methods for producing ranibizumab. Provided herein are methods of producing a recombinant protein... |
|
|
Invention
|
Methods of purifying ranibizumab or a ranibizumab variant. Provided herein are processes for manu... |
|
|
Invention
|
Control mechanism for priming an injection device.
An injection device includes a syringe barrel... |
|
|
Invention
|
Control mechanism for priming an injection device. An injection device includes a syringe barrel ... |
|
|
Invention
|
Etanercept formulations exhibiting marked reduction in sub-visible particles.
The invention prov... |
|
|
Invention
|
Etanercept formulations stabilized with xylitol.
The invention provides stabilized aqueous phar... |
|
|
Invention
|
Stable aqueous formulations of aflibercept. A stable aqueous pharmaceutical formulation comprisin... |
|
|
Invention
|
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy. The present i... |
|
|
Invention
|
Compositions and methods to treat cancer.
Provided herein are methods and combination therapies ... |
|
|
Invention
|
Compositions and methods to treat cancer. Provided herein are methods and combination therapies u... |
|
|
Invention
|
Method of producing a recombinant protein. Provided herein are methods of producing a recombinant... |
|
2019
|
Invention
|
Process for producing, isolating, and purifying modified recombinant proteins.
The invention pro... |
|
|
Invention
|
Process for producing, isolating, and purifying modified recombinant proteins. The invention prov... |
|
|
Invention
|
Methods for producing recombinant proteins.
Provided herein are methods of producing a recombina... |
|
|
Invention
|
Methods for producing recombinant proteins. Provided herein are methods of producing a recombinan... |
|
|
Invention
|
Etanercept formulations stabilized with sodium chloride. The invention provides stabilized aqueou... |
|
|
Invention
|
Etanercept formulations stabilized with sodium chloride.
The invention provides stabilized aqueo... |
|
|
Invention
|
Etanercept formulations stabilized with meglumine.
The invention provides stabilized aqueous pha... |
|
|
Invention
|
Correctly folded etanercept in high purity and excellent yield. A mixed mode chromatography metho... |
|
|
Invention
|
Methods of treating subjects with an elevated neurofilament light chain level. Provided herein ar... |
|
2018
|
Invention
|
Ppary agonist for treatment of progressive supranuclear palsy. Methods of treatment of progressiv... |
|
|
Invention
|
Ppary agonist for treatment of huntington's disease.
Methods of treatment of Huntington's diseas... |
|
2017
|
Invention
|
Ppar-gamma agonist for treatment of blood cancers.
Methods of treatment of blood cancers includi... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of auto-immune diseases. |
|
2016
|
Invention
|
Stable aqueous formulations of natalizumab.
Described herein is a stable aqueous pharmaceutical ... |
|
|
P/S
|
Pharmaceuticals. Manufacturing services for others in the field of
pharmaceutical products. Rese... |
|
|
P/S
|
Pharmaceuticals used for stimulating white blood cell production; pharmaceutical preparations for... |
|
|
P/S
|
Pharmaceutical preparations for treating human immune
diseases and conditions. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune disease... |
|
2015
|
P/S
|
pharmaceuticals for use in stimulating white blood cell production research, development and cons... |
